YCM
VRTX icon

Yousif Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Yousif Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
21,685
-1,682
-7% -$745K 0.12% 140
2026
Q1 		$10.4M Sell
23,367
-937
-4% -$437K 0.12% 145
2025
Q4 		$10.7M Sell
24,304
-1,358
-5% -$585K 0.12% 149
2025
Q3 		$10.1M Sell
25,662
-455
-2% -$190K 0.11% 162
2025
Q2 		$11.6M Sell
26,117
-304
-1% -$140K 0.13% 145
2025
Q1 		$12.8M Sell
26,421
-664
-2% -$309K 0.15% 129
2024
Q4 		$10.9M Sell
27,085
-1,203
-4% -$558K 0.12% 149
2024
Q3 		$13.2M Sell
28,288
-305
-1% -$147K 0.14% 130
2024
Q2 		$13.4M Sell
28,593
-471
-2% -$204K 0.15% 117
2024
Q1 		$12.1M Sell
29,064
-2,154
-7% -$911K 0.13% 135
2023
Q4 		$12.7M Sell
31,218
-2,576
-8% -$952K 0.15% 124
2023
Q3 		$11.8M Sell
33,794
-873
-3% -$305K 0.15% 125
2023
Q2 		$12.2M Buy
34,667
+606
+2% +$204K 0.15% 127
2023
Q1 		$10.7M Sell
34,061
-1,802
-5% -$540K 0.14% 139
2022
Q4 		$10.4M Buy
35,863
+3,777
+12% +$1.15M 0.14% 145
2022
Q3 		$9.29M Sell
32,086
-267
-0.8% -$76.8K 0.13% 141
2022
Q2 		$9.12M Sell
32,353
-910
-3% -$244K 0.12% 161
2022
Q1 		$8.68M Buy
33,263
+115
+0.3% +$27.3K 0.09% 199
2021
Q4 		$7.28M Buy
+33,148
New +$6.45M 0.08% 248

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Yousif Capital Management's VRTX Position: Q2 2026 in Review

Yousif Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 7.2% in Q2 2026, selling an estimated $745K and leaving 21,685 shares worth $10.8M. The position accounts for 0.12% of the portfolio, ranked #140.

Yousif Capital Management first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.4M in Q2 2024. 365 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Yousif Capital Management held 21,685 shares of Vertex Pharmaceuticals worth $10.8M as of Q2 2026.
  • Yousif Capital Management sold 1,682 Vertex Pharmaceuticals shares in Q2 2026, an estimated $745K.
  • Vertex Pharmaceuticals made up 0.12% of Yousif Capital Management's portfolio in Q2 2026, its #140 holding.
  • Yousif Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Vertex Pharmaceuticals position peaked at $13.4M in Q2 2024.
  • 365 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.